SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001214659-23-007002
Filing Date
2023-05-15
Accepted
2023-05-15 06:02:49
Documents
48
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 hgen-20230331.htm   iXBRL 10-Q 329260
2 GRAPHIC pipeline.jpg GRAPHIC 131634
3 EXHIBIT 31.1 ex31_1.htm EX-31.1 7237
4 EXHIBIT 31.2 ex31_2.htm EX-31.2 7309
5 EXHIBIT 32.1 ex32_1.htm EX-32.1 3610
6 EXHIBIT 32.2 ex32_2.htm EX-32.2 3804
  Complete submission text file 0001214659-23-007002.txt   2433174

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE hgen-20230331.xsd EX-101.SCH 33413
8 XBRL CALCULATION FILE hgen-20230331_cal.xml EX-101.CAL 15013
9 XBRL DEFINITION FILE hgen-20230331_def.xml EX-101.DEF 114799
10 XBRL LABEL FILE hgen-20230331_lab.xml EX-101.LAB 238009
11 XBRL PRESENTATION FILE hgen-20230331_pre.xml EX-101.PRE 128549
42 EXTRACTED XBRL INSTANCE DOCUMENT hgen-20230331_htm.xml XML 123443
Mailing Address 830 MORRIS TURNPIKE 4TH FLOOR SHORT HILLS NJ 07078
Business Address 830 MORRIS TURNPIKE 4TH FLOOR SHORT HILLS NJ 07078 (973) 200-3100
HUMANIGEN, INC (Filer) CIK: 0001293310 (see all company filings)

IRS No.: 770557236 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35798 | Film No.: 23918072
SIC: 2834 Pharmaceutical Preparations